Skip to the page

Data / Form D filings / Ilico Genetics, Inc.

Ilico Genetics, Inc.: Form D filing

Ilico Genetics, Inc., a biotechnology company in Bethlehem, PA, filed a Form D with the SEC in 2023. The latest, on October 27, 2023, reports $457,735 sold of an offering with no set size to 10 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
116 RESEARCH DRIVE, SUITE 141, Bethlehem, PA, 18015
Phone
(484) 264-3002
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2022
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1998307

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 27, 2023New noticeIndefinite$457,73510Jan 25, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Maria Jose Maturana RojasDirector
Alejandro Hernan Corvalan RodriguezDirector
Fernando A Alarcon HardyExecutive Officer, Director

Other biotechnology companies in Pennsylvania that filed recently

Every Form D from the week of Oct 23, 2023 · All recent filings in Pennsylvania · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Ilico Genetics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.